MARK STEVEN BERNARD MD NPI 1780635508

NPI Details

Mark Steven Bernard, MD is a nuclear medicine in Fresno, CA with 28 years of experience. The provider is a nuclear medicine specialist employs the properties of radioactive atoms and molecules in the diagnosis and treatment of disease and in research. Radiation detection and imaging instrument systems are used to detect disease as it changes the function and metabolism of normal cells, tissues and organs. A wide variety of diseases can be found in this way, usually before the structure of the organ involved by the disease can be seen to be abnormal by any other techniques. Early detection of coronary artery disease (including acute heart attack), early cancer detection and evaluation of the effect of tumor treatment, diagnosis of infection and inflammation anywhere in the body and early detection of blood clot in the lungs are all possible with these techniques. Unique forms of radioactive molecules can attack and kill cancer cells (e.g., lymphoma, thyroid cancer) or can relieve the severe pain of cancer that has spread to bone Mark Steven Bernard, MD NPI is 1780635508. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL COLLEGE OF WISCONSIN
Graduation Year:1997

The provider's business location address is:

1303 E HERNDON AVE
FRESNO, CA
ZIP 93720-309
Phone: (559) 450-3109

The NPI 1780635508 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician (HCPCS:93018)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician (HCPCS:93016)
• Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Nuclear medicine study of lung circulation (HCPCS:78580)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Nuclear medicine study of liver and bile duct system (HCPCS:78226)
• Nuclear medicine study of bone taken at different times (HCPCS:78315)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Nuclear medicine study, 1 area with spect and concurrent ct scan (HCPCS:78830)
• Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries (HCPCS:A9541)
• Nuclear medicine study of stomach to assess emptying (HCPCS:78264)
• Nuclear medicine study of stomach to assess emptying (HCPCS:78264)
• Nuclear medicine study of parathyroid (HCPCS:78070)
• Nuclear medicine study of bone taken at different times (HCPCS:78315)
• Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries (HCPCS:A9562)
• Nuclear medicine study of kidney, blood, flow, and function with drug administration (HCPCS:78708)
• Radioactive drug therapy through a tube inserted in an artery (HCPCS:79445)
• Calculation of radiation therapy dose (HCPCS:77300)
• Nuclear medicine study of heart muscle at rest and with stress and spect (HCPCS:78451)
• Nuclear medicine study to assess blood loss (HCPCS:78278)
• Nuclear medicine study of thyroid and thyroid function (HCPCS:78014)
• Nuclear medicine study, 1 area (HCPCS:78800)
• Nuclear medicine study of liver and bile duct system with use of drugs (HCPCS:78227)
• Nuclear medicine study of kidney, blood, flow, and function with drug administration (HCPCS:78708)
• Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved (HCPCS:77290)
• Nuclear medicine study of liver and bile duct system (HCPCS:78226)
• Nuclear medicine study, whole body (HCPCS:78802)
• Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries (HCPCS:A9537)

The enumeration date for this NPI number is 5/15/2006 and was last updated on 1/12/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.